Long-Term Survival And Good QOL Is Possible in Prostate Cancer With Bone Mets
The development of bone metastases is often been viewed as having significant negative implications for long term survival in men with metastatic castrate resistant prostate cancer (mCRPC). It is generally believed that bone metastases prognosticates [...]
Remembering Andrew And Learning From A 28 Year Old Wise Man
Yesterday, my younger son Max, who is 28 years old, went to the funeral of a fraternity brother. Actually, the young man, Andrew, had been a member of his pledge class at the University of [...]
Are You Having Trouble Getting Early Access To Chemotherapy?
During last year’s American Society of Clinical Oncologists (ASCO) Annual Meeting, data was released from the STAMPEDE trial which should change clinical practice around the world. The trial results showed that newly diagnosed men with [...]
Metabolic Syndrome in Men with Castration-Resistant Prostate Cancer Treated with Abiraterone Affects Their Survival
Yesterday’s post was about the increased risks of developing diabetes faced by men who are on hormone therapy. This study, as well as most others about this topic has looked at the first levels of [...]
Hormone Therapy (ADT) Increases By 60% A Man’s Risk of Developing Diabetes
According to a recent study published in the Journal of Urology, men with localized prostate cancer on hormone therapy (ADT) have a significant increase in their risk for developing diabetes. In this retrospective study of [...]
Skeletal Events and the Treatment of Men with Advanced Prostate Cancer
Many of our doctors are constantly vigilant about our developing skeletal related issues. Having advanced prostate cancer and receiving treatment for this disease increases our odds of developing skeletal issues which affect both our quality [...]